Gallo's 1984 Study Found HIV in Saliva

Gallo found the AIDS bicho in saliva in 1984, with no consequences

April 1984. A press room in Washington. Margaret Heckler, US Secretary of Health, and Robert Gallo from the National Cancer Institute stood side by side. That day, the world was told that the "AIDS bicho" had a name: HTLV-III. The photo became history. The supporting paper, published shortly before, contained a detail almost nobody read: the bicho also appeared in saliva.

The title leaves no doubt: "HTLV-III in saliva of people with AIDS-related complex and healthy gai men at risk for AIDS." This was not an anecdotal finding. It was the same agent just presented as the cause of a deadly epidemic, detected in a fluid we all exchange when speaking.

What Gallo’s paper found in saliva

The article summary details the distribution: HTLV-III was isolated in the saliva of 8 out of 18 seropositive individuals. Four were patients with ARC (AIDS-related complex) and four were healthy lgtb men at risk for AIDS. Thus, the bicho was present in both sick and asymptomatic people.

And a final sentence that has aged poorly: "Although AIDS does not appear to be transmitted by casual contact, the possibility that HTLV-III can be transmitted by saliva should be considered." Translated: although AIDS doesn't seem to spread via casual contact, one should consider the possibility that HTLV-III spreads through saliva. Signed by the man who had just put a face on the discovery.

Why isn’t saliva listed among HIV transmission routes today?

The official answer hasn't changed since then: saliva contains much lower viral concentrations than blood or leche and includes replication-inhibiting factors, such as the protein SLPI, studied mainly in dentistry due to occupational exposure. Additionally, mucosal barriers exist, and there are no documented cases of infection via kissing, shared utensils, or sneezing.

A recurring objection is that no conclusive studies establish the minimum viral load needed to infect via this route, nor adequate comparisons between seropositive and seronegative samples. Detecting genetic material or particles does not equal transmission. This nuance is often lost in discussions about the topic.

Tears, the other uncomfortable fluid

The pattern repeated. In 1985, a team including Gallo isolated HTLV-III in the tears of an AIDS patient. The work, signed by Fujikawa, Salahuddin, Palestine, Masur, Nussenblatt, and Gallo himself, was indexed but did not alter hospital protocols. In 2011, HIV-1 detection in tears of patients on long-term antiretroviral therapy was published.

This leads to the most repeated argument: if the bicho appears in saliva and tears, why is the list of transmission routes limited to blood, leche, vaginal fluid, and breast milk? If presence were the criterion, the list would be much longer.

The movement denying HIV and its limits

This contradiction has fueled a movement going further: those claiming HIV does not cause AIDS. References include biochemist Kary Mullis, 1993 Nobel Prize in Chemistry; virologist Heinz Ludwig Sänger, 1978 Robert Koch Prize winner; and biologist Peter Duesberg, who attributes immunodeficiency to prolonged drug use.

These positions are minority views without experimental backing: the link between HIV and AIDS is supported by nearly all peer-reviewed literature, clinical trials, and responses to antiretrovirals. Proponents argue that consulted specialists haven't identified primary studies isolating the bicho or proving its causal link to AIDS.

The Bergalis case and the mystery never closed

Kimberly Bergalis became the face of unexplained transmission: a young woman reportedly infected at a dentist's office without a clear route identified. In unexplained transmission cases, arguments go, nobody proposes saliva or tears as working hypotheses. The official explanation is that a route existed—dental instruments—but the episode fueled years of suspicion that criteria are applied selectively to fit narratives.

Ten billion particles daily unseen without manipulation

One widely circulated datum: in HIV-1, average estimated production is approximately 1×10^10 virions per day, ten billion new particles. With this figure, questions arise why the bicho isn't observed in direct samples and why co-culturing with stimulated cell lines is needed to see virions. Some claim applying the same process to non-infected samples yields morphologically indistinguishable particles.

This is technical ground full of nuances: microscopy requires specific preparations, and culture methods have limits. But the figure serves its purpose: asking why an agent calculated at ten billion daily copies cannot be photographed without assistance.

Gallo’s paper remains indexed, with its intact warning about saliva. The HIV transmission route list remains unchanged. Between these two facts lies no reconciling study, only four decades of administrative silence.